Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy
Karl H. Schuleri(Johns Hopkins University), Joshua M. Hare(University of Miami Health System), Eric S. Weiss(University of Pittsburgh), Joshua Kellner(The University of Texas MD Anderson Cancer Center), Jeffrey Zimmet(Johns Hopkins University), Charles Steenbergen(Johns Hopkins University), Gary Feigenbaum(University of Miami), Jennifer Turney(Johns Hopkins University), Michael Centola(Johns Hopkins University), Albert C. Lardo(Johns Hopkins University), Konstantinos E. Hatzistergos(University of Miami), J.V. Conte(Johns Hopkins University), Barbara Detrick(National Institutes of Health), Ian McNiece(Clinical Research of South Florida), Menekhem M. Zviman(Johns Hopkins University)
Cited by 251
Related Papers
2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology
|Cardiovascular Pathology|2011|528
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
|Blood|2018|402
Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy
|Journal of the American College of Cardiology|2016|357
Creation of a Quantitative Recipient Risk Index for Mortality Prediction After Cardiac Transplantation (IMPACT)
|The Annals of Thoracic Surgery|2011|243